Apontis Pharma AG
XETRA:APPH
Apontis Pharma AG
Cash Taxes Paid
Apontis Pharma AG
Cash Taxes Paid Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Taxes Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Apontis Pharma AG
XETRA:APPH
|
Cash Taxes Paid
€463.4k
|
CAGR 3-Years
37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Cash Taxes Paid
$1.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bayer AG
XETRA:BAYN
|
Cash Taxes Paid
€1.2B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-1%
|
|
|
Merck KGaA
XETRA:MRK
|
Cash Taxes Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Cash Taxes Paid
€81.3m
|
CAGR 3-Years
24%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Cash Taxes Paid
€3.9m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
Apontis Pharma AG
Glance View
APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. The company is headquartered in Monheim Am Rhein, Nordrhein-Westfalen and currently employs 176 full-time employees. The company went IPO on 2021-05-11. The firm focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
See Also
What is Apontis Pharma AG's Cash Taxes Paid?
Cash Taxes Paid
463.4k
EUR
Based on the financial report for Dec 31, 2023, Apontis Pharma AG's Cash Taxes Paid amounts to 463.4k EUR.
What is Apontis Pharma AG's Cash Taxes Paid growth rate?
Cash Taxes Paid CAGR 3Y
37%
Over the last year, the Cash Taxes Paid growth was 12 095%. The average annual Cash Taxes Paid growth rates for Apontis Pharma AG have been 37% over the past three years .
You don't have any saved screeners yet